The Indian injectable manufacturing market is showcasing robust demand for biologics, and increased capacity in generic injectables Today, the key trends include AI-driven production, CDMO growth, and prefilled syringes. However, the industry comes with its own set of dire challenges that revolve around stringent USFDA compliance, high capital investment, and complex sterility validations. Hence, all the stakeholders must bring in their involvement to drive this sector further.
One trend that has been showcasing quite the traction has to be the third-party manufacturing with... >>More
Sandeep Raktate, President - Operations (India & Ireland), Amneal Pharmaceuticals
Saransh Chaudhary, President - Global Critical Care (Venus Remedies) & CEO, Venus Medicine Research Centre
Vikram Aditya Sehgal, Director – Finance, Centrient India
Nandakumar Kalathil, AVP - Sales (India), Agilent Technologies
Rajiv Gupta, Country Business Leader (Healthcare Business), 3M India
Dr. Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis